Biologic-like In Vivo Efficacy with Small Molecule Inhibitors of TNFα Identified Using Scaffold Hopping and...

Area of Science:

• Medicinal Chemistry
• Structural Biology
• Pharmacology

Background:

• Tumor necrosis factor alpha (TNFα) is a key mediator in inflammatory diseases.
• Developing small molecule inhibitors for TNFα remains a therapeutic challenge.

Purpose of the Study:

• To identify potent small molecule inhibitors of TNFα using scaffold hopping and structure-based drug design.
• To characterize the mechanism of action and in vivo efficacy of novel TNFα inhibitors.

Main Methods:

• Scaffold hopping and structure-based drug design were utilized to discover novel inhibitors.
• X-ray co-crystal structure analysis and ultracentrifugation elucidated the binding mechanism.
• Pharmacokinetic-pharmacodynamic studies and in vivo efficacy models (collagen antibody-induced arthritis) were employed.

Main Results:

• Substituted 4-aminoquinolines and 4-aminonaphthyridines were identified as potent TNFα inhibitors.
• Compound 42 exhibited excellent potency and a favorable pharmacokinetic profile.
• Inhibitors were shown to distort the TNFα trimer, disrupting signaling pathways.

Conclusions:

• Novel small molecules targeting TNFα have been developed with promising therapeutic potential.
• Compound 42 demonstrates significant in vivo efficacy in relevant disease models.
• Understanding the mechanism of TNFα trimer distortion provides insights for future drug development.